Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New ultrasound measure may better predict Baby's age

NCT ID NCT07169929

Knowledge-focused Sponsor: Cairo University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether measuring a specific part of the fetal brain (the thalamus) using 2D ultrasound can reliably estimate how far along a pregnancy is. Researchers measured the thalamus in 110 pregnant women between 18 and 36 weeks. The goal was to see if this measurement matches known formulas for gestational age and could serve as a new growth parameter.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could give doctors a new, simple ultrasound measurement to help estimate fetal age and growth.
What could go wrong
This is a small, completed observational study, not a treatment trial. The measurement may not be more accurate than existing methods and depends heavily on the operator's skill.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

110 people

The number who actually took part.

Started

Sep 2025

Finished

Mar 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Healthy pregnant women who will meet the inclusion criteria and attend the feto-maternal unit in the department of obstetrics and gynecology faculty of medicine Cairo university consent to participate in the research study

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * All pregnant women with singleton pregnancy with gestational age between 18 to 36 weeks Exclusion Criteria: * Women who are not sure of dates and don't have an US report with CRL measured in the first trimester * Maternal obesity (BMI\>35) as abdominal fat cause restriction in taking measurement * Known case of DM or Hypertension or SLE * Any fetal head or CNS anomalies * Any maternal opiates and CNS drugs (methadone) IUGR * Twins or multiple pregnancy

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Fetal conditions are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Fetal conditions

Contacts and locations

Locations

  • Shaimaa El Shemy

    Giza, Cairo Governorate, 4240310, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.